Key Takeaways Inspire Medical reported Q3 EPS of 38 cents, ahead of the expected loss of 15 cents.INSP's Q3 revenues rise to $224.5 million, driven by market reach and therapy awareness.Inspire Medical raised 2025 EPS guidance to 90 cents to $1.00 while maintaining revenue outlook.Inspire Medical Systems, Inc. (INSP) delivered adjusted earnings per share (EPS) of 38 cents in third-quarter 2025, down 36.7% year over year. The figure compares with the Zacks Consensus Estimate of a loss of 15 cents.INSP’s Reve ...